Practical tips on achieving Impact and Investment Fund payments of over £21,100 from just three work streams were presented by DDA Board Member and pharmacist partner Mark Stone at the end of day one of the DDA conference.
The presentation looked at the following three work streams, which collectively currently have a potential IIF score of 601 and a value of £21,111:
- Influenza vaccine uptake
- Cardiovascular disease prevention
- Respiratory disease and green inhalers.
Summarising the opportunity, he said: “For once general practice has access to a significant capital investment fund.”
In general advice to practices, Mr Stone said practices could:
- review all PCN IIF indcators by the highest number of points
- understand and grade IIF indicators on the cost of effort, the financial reward and the patient benefit
- classify and group those IIF indicators that are closely related to maximise cross opportunities
- ensure each member of the practice staff is empowered to fulfil IIF targets
- create visual prompts on the practice IT system.
For example, non-clinicians can fulfil IIF workstreams including ethnicity recording, promoting the flu vaccine service, referrals to services such as community pharmacy consultation (CPCS), social prescribing and finding patients with a BP of over 140.90mmHg who are not diagnosed or treated to target.
He said that in 2022-23, the IIF would be worth £223 million to practices in England, rising to an expected £300m in 2023-24. This is up from £24.25m in 2020-21, and currently is worth approximately £40,400 per average practice.
View the presentation: PCNs and beyond. All presentations can be found on the online DDA conference page